P2.04-54 Characteristic of MSI-H Lung Cancer Patients Identified with Targeted Next-Generation Sequencing

Xuefeng Xia(BGI Group (China)), Guofu Lin(Fujian Medical University), Yu Yi(Xuzhou Medical College), Meng Yuan(Unknown), Jun Zhao(Beijing Institute of Technology), Y. Guan, R. Chen

Journal of Thoracic Oncology

October 1, 2019

10.1016/j.jtho.2019.08.1559

Cited by 4

Related Papers

Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial

|The Lancet Respiratory Medicine|2020|504

Addictive Screen Use Trajectories and Suicidal Behaviors, Suicidal Ideation, and Mental Health in US Youths

|JAMA|2025|58

Neutrophil Percentage-to-Albumin Ratio and Risk of Mortality in Patients on Peritoneal Dialysis

|Journal of Inflammation Research|2023|46

Citric Acid Promotes Immune Function by Modulating the Intestinal Barrier

|International Journal of Molecular Sciences|2024|41

Targeting complement C5a to improve radiotherapy sensitivity in non-small cell lung cancer

|Translational Lung Cancer Research|2023|19